Back to LCTX
Essential Partners LLC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
7
Latest value
$103K
Q3 2026
Peak value
$127K
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $308 |
| Q2 2025 | $5K |
| Q3 2025 | $15K |
| Q4 2025 | $57K |
| Q1 2026 | $96K |
| Q2 2026 | $127K |
| Q3 2026 | $103K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $103K | 3.0K | — | — |
| Q2 2026 | $127K | 2.9K | — | — |
| Q1 2026 | $96K | 2.9K | — | — |
| Q4 2025 | $57K | 1.6K | — | — |
| Q3 2025 | $15K | 399 | — | — |
| Q2 2025 | $5K | 119 | — | — |
| Q2 2025 | $308 | 339 | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M